(5-bromopyridin-2-yl)-(4-chlorophenyl)methanone结构式
|
常用名 | (5-bromopyridin-2-yl)-(4-chlorophenyl)methanone | 英文名 | (5-bromopyridin-2-yl)-(4-chlorophenyl)methanone |
|---|---|---|---|---|
| CAS号 | 917899-52-6 | 分子量 | 296.54700 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C12H7BrClNO | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | (5-bromopyridin-2-yl)-(4-chlorophenyl)methanone |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C12H7BrClNO |
|---|---|
| 分子量 | 296.54700 |
| 精确质量 | 294.94000 |
| PSA | 29.96000 |
| LogP | 3.72850 |
|
~32%
(5-bromopyridin... 917899-52-6 |
| 文献：ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 208-209 ; WO 2006/136830 A1 |
| (4-chloro-phenyl)-(5-bromo-pyridin-2-yl)-methanone |
| Methanone,(5-bromo-2-pyridinyl)(4-chlorophenyl) |
